Arintra Secures $21M Series A Funding Led by Peak XV Partners for AI Medical Coding

San Francisco-based Arintra, an autonomous medical coding platform, has secured $21 million in Series A funding, led by Peak XV Partners and supported by Endeavor Health Ventures, Y Combinator, Counterpart Ventures, Spider Capital, Ten13, and other investors.

At a time when hospitals and clinics face increasing operational pressures, Arintra’s platform offers a practical way to navigate the complexity of medical billing. The company has developed a generative AI-powered platform that automates medical coding, streamlines documentation, and helps providers secure accurate reimbursement. By integrating seamlessly with widely used electronic health record systems, Arintra provides a solution that efficiently reduces the risk of errors, which can otherwise lead to costly delays or claim denials.

Healthcare organizations face growing pressure from multiple fronts. Rising operational costs, shrinking margins, and the constantly evolving regulations from payers create a challenging environment for hospitals and physician practices. Every delay, error, or incomplete documentation can have a significant financial impact. At the same time, a shortage of trained medical coders adds to the strain, as even minor errors can snowball into substantial revenue losses. Arintra addresses these challenges directly by automating the coding process, ensuring accuracy, and supporting compliance. The platform enables healthcare teams to focus more on patient care rather than administrative tasks, while also enhancing the efficiency and reliability of the revenue cycle.

Arintra stands out because of the breadth of its platform. It does more than automate coding; it also supports clinical documentation improvement and denial prevention. In practice, this means providers can better document patient care, accurately code procedures, and submit claims with the supporting evidence necessary to prevent denials.